GlaxoSmithKline | GSK - Чистый доход

Биржевая цена
1,921.50
Изменение за день
3.50 0.18%
Ежемесячно
-6.90%
Ежегодный
31.34%
Q2 прогноз
1,986.06




Чистый доход Изменить Дата
AbbVie USD 695M 1.12B 2026-03
Alcon AG USD 217M 20M 2025-12
Almirall EUR 19.58M 7M 2025-12
Amgen USD 1.33B 1.88B 2025-12
argenx SE USD 532.95M 188.69M 2025-12
AstraZeneca USD 3.08B 754M 2026-03
Bayer EUR -3.76B 2.79B 2025-12
Biogen USD 319.5M 368.4M 2026-03
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Fresenius EUR 361M 17M 2025-12
Fresenius Medical Care EUR 327M 52.2M 2025-12
Galapagos EUR 782.15M 984.26M 2025-12
Genmab DKK 31M 370M 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
Glaxosmithkline GBP 846.06M 1.87B 2025-12
GRIFOLS EUR 98.25M 28.72M 2025-12
Hikma Pharmaceutical USD 164M 45M 2025-12
Lonza CHF 426M 119M 2025-06
Merck EUR 319M 583M 2025-12
Merck USD 2.96B 2.82B 2025-12
Novartis USD 3.16B 747M 2026-03
Novo Nordisk DKK 26.89B 388M 2025-12
Orion EUR 90.4M 170.1M 2026-03
Pfizer USD -1.65B 5.19B 2025-12
Philips EUR 395M 211M 2025-12
Recordati EUR 117.31M 7.15M 2025-12
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR 1.61B 2.42B 2026-03
Smith & Nephew USD 293M 79M 2025-12
UCB EUR 1.08B 608M 2025-12